Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in ranbaxy

Damages Outside Of Contract: Lessons From Daiichi-Ranbaxy

Damages generally have a contractual basis, where the aim is to provide an approximate monetary equivalent of an unfulfilled promise

Read More

Mockery Of Corporate Governance: The Sun Pharma Way

Sun Pharma has not only violated the good corporate governance in terms of transparency but also consciously tried to make the investors believe that there is no plan to either divest assets or to cut jobs by strongly denying the then true media reports

Read More

Pharma Crusader Takes Drug Regulators To Court

Dinesh Thakur made his name, and almost $48 million as a whistleblower award from the United States, when US regulators fined Ranbaxy $500 million for violating federal drug safety laws

Read More

Remembering Aditya Birla

Sutanu Guru argues how the late Aditya Birla was a true pioneer of globalization Twenty years ago on this day, the then 28 year old Kumar Manglam Birla confronted both tragedy and challenge. His father Aditya Birla passed away at a very early age of 52 in the United States after a brief and valiant fight with cancer.

Read More